Public/Private Sector Partnership For Emerging Infections

Public/private sector partnership for emerging infections.

This paper gives examples of public/private partnerships that support research, support drug development and that advance policy development, suggesting that such partnerships can advance our understanding and control of emerging infections. The investment in emerging infectious diseases from government and from industry is currently much larger than that from philanthropy. Nevertheless philant...

Vaccines for emerging infections.

Emerging infectious diseases represent a grave threat to animal and human populations in terms of their impact on global health, agriculture and the economy. Vaccines developed for emerging infections in animals can protect animal health and prevent transmission of zoonotic diseases to humans. Examples in this paper illustrate how industry and public health can collaborate to develop a vaccine ...

Climate changes and emerging fungal infections

Background: Candida auris is a globally emerging yeast pathogen that has shown not only resistance to most anti-fungal drugs but also thermo-tolerance to temperatures higher than the mammalian’s body temperature. Although it has been only a decade since the fungus was identified, its spread of infections has been rapid and quasi-epidemics have been reported. Co-occurrences of the fungus infecti...

A Model for Public-Private Partnership in the Public Services Sector

Public-private partnership is a new way to expand public services through the private sector, which should be increasingly taken into consideration in Iran. This research aims at identifying effective factors in the success of public-private partnership and providing a model for the public services sector in Iran. The data collection tool was a questionnaire and the analytical unit and the stat...

Private Sector Development and Partnership Strategy